A 9 week study to evaluate the treatment of DS-5565 for neuropathic pain in subjects with Diabetic Peripheral Neuropathy.

• Male/Female, age 18 years or older.
• Type I or II Diabetes with HbA1c < or = 10%, on a stable anti-diabetic medication with painful polyneuropathy (both legs or feet).